Home / Healthcare / Pulmonary Arterial Hypertension Treatment Market

Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Share and Analysis by Drug Class (Soluble Guanylate Cyclase (SGC) Stimulators,Prostacyclin and Prostacyclin Analogs, Phosphodiesterase 5 (PDE-5), Endothelin Receptor Antagonists (ERA)), By End User (Hospitals, Clinics, Others), and Regional Forecast, 2025-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI101003 | Status : Upcoming
  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients